These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6758934)

  • 1. Should ventricular premature depolarizations be treated? If so, how?
    Aronow WS
    Cardiology; 1982; 69 Suppl():225-34. PubMed ID: 6758934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications.
    Surawicz B
    J Am Coll Cardiol; 1987 Aug; 10(2):435-47. PubMed ID: 3298363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which postinfarction ventricular arrhythmias should be treated?
    Bigger JT; Weld FM; Rolnitzky LM
    Am Heart J; 1982 Apr; 103(4 Pt 2):660-6. PubMed ID: 6175196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of sudden death risk factors in acute and chronic coronary artery disease.
    Vismara LA; Vera Z; Foerster JM; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 May; 39(6):821-8. PubMed ID: 871108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy.
    Chakko CS; Gheorghiade M
    Am Heart J; 1985 Mar; 109(3 Pt 1):497-504. PubMed ID: 3976476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 1988 Aug; 14(8):25-30. PubMed ID: 3048863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex ventricular arrhythmias after myocardial infarction during convalescence and follow-up: a harbinger of multi-vessel coronary disease, left ventricular dysfunction and sudden death.
    Taylor GJ; Humphries JO; Pitt B; Griffith LS; Achuff SC
    Johns Hopkins Med J; 1981 Jul; 149(1):1-5. PubMed ID: 7253362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience.
    Bigger JT
    Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
    de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ventricular arrhythmias in the coronary patient: what sort of patient? For which rhythm disorder? With which procedure?
    Olsson G; Rehnqvist N
    Am J Cardiol; 1989 Dec; 64(20):57J-60J. PubMed ID: 2596413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with malignant or potentially malignant ventricular arrhythmias: opportunities and limitations of drug therapy in prevention of sudden death.
    Bigger JT
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):23B-26B. PubMed ID: 3889110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug prevention and therapy of ventricular tachycardia].
    Burckhardt D; Hoffmann A
    Ther Umsch; 1992 Aug; 49(8):543-9. PubMed ID: 1519183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular ectopy and sudden death.
    Rozanski JJ; Castellanos A; Myerburg RJ
    Cardiovasc Clin; 1980; 11(1):127-42. PubMed ID: 7002298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory electrocardiographic monitoring: can we predict sudden death?
    Armstrong WF; McHenry PL
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):13B-16B. PubMed ID: 3889105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs.
    Graboys TB; Lown B; Podrid PJ; DeSilva R
    Am J Cardiol; 1982 Sep; 50(3):437-43. PubMed ID: 6180622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.